Delivery Order SPE2DB24D8001-SPE2DB25FKYVY

Award Date 11/19/24
Potential Completion Date 11/20/24
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKYVY
    Delivery Order

This federal contract award, ID SPE2DB24D8001|SPE2DB25FKYVY, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,566,491,125 units of the medication Eliquis 5 mg Tablet 60s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,648.27 and a period of performance through November 20, 2024. Dakota Drug, Inc. is the prime contractor, and this award is not associated with a set-aside program. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations through a larger Indefinite Delivery Contract valued at $999,999,999.00.

Generated 2/18/25, 1:41 PM